CiteFacts · FDA Drug Shortages · FDA source
Dobutamine Hydrochloride Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02) | Available | 08/17/2026 |
| Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02) | Available | 08/17/2026 |
| Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02) | Available | 08/17/2026 |
| Hainan Poly Pharm. Co., Ltd. | Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80) | Available | 05/08/2026 |
| Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-2346-32) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88) | Unavailable | 08/07/2026 |
| Pfizer Inc. | Dobutamine Hydrochloride, Injection, 12.5 mg/1 mL (NDC 0409-2344-88) | Not stated | 08/27/2025 |
Source facts
Grouped generic ingredient: Dobutamine Hydrochloride Injection · 11 package records · Latest FDA row update: 08/27/2025
Therapeutic categories: Cardiovascular, Pediatric, Renal
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.